TreeWAS – Variant ID: rs13406665

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Showing all nodes without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
D12.0 Caecum	0.000	0.358	0.642
I83.9 Varicose veins of lower extremities without ulcer or inflammation	0.000	0.372	0.628
D12 Benign neoplasm of colon, rectum, anus and anal canal	0.000	0.408	0.592
C78.6 Secondary malignant neoplasm of retroperitoneum and peritoneum	0.576	0.424	0.000
C78 Secondary malignant neoplasm of respiratory and digestive organs	0.572	0.428	0.000
D12.3 Transverse colon	0.000	0.429	0.571
D12.5 Sigmoid colon	0.000	0.446	0.554
C78.2 Secondary malignant neoplasm of pleura	0.553	0.447	0.000
C78.0 Secondary malignant neoplasm of lung	0.508	0.492	0.000
D12.2 Ascending colon	0.000	0.498	0.502
D12.4 Descending colon	0.000	0.507	0.493
C76-C80 Malignant neoplasms of ill-defined, secondary and unspecified sites	0.465	0.535	0.000
C78.5 Secondary malignant neoplasm of large intestine and rectum	0.464	0.536	0.000
C78.4 Secondary malignant neoplasm of small intestine	0.458	0.542	0.000
C78.3 Secondary malignant neoplasm of other and unspecified respiratory organs	0.452	0.548	0.000
C77 Secondary and unspecified malignant neoplasm of lymph nodes	0.450	0.550	0.000
C77.4 Inguinal and lower limb lymph nodes	0.448	0.552	0.000
D12.1 Appendix	0.000	0.558	0.442
D12.7 Rectosigmoid junction	0.000	0.571	0.429
C78.7 Secondary malignant neoplasm of liver	0.403	0.597	0.000
D12.9 Anus and anal canal	0.000	0.605	0.395
C77.9 Lymph node, unspecified	0.389	0.611	0.000
C77.5 Intrapelvic lymph nodes	0.388	0.612	0.000
C76 Malignant neoplasm of other and ill-defined sites	0.386	0.614	0.000
C77.8 Lymph nodes of multiple regions	0.373	0.627	0.000
C80 Malignant neoplasm without specification of site	0.358	0.642	0.000
C78.8 Secondary malignant neoplasm of other and unspecified digestive organs	0.340	0.660	0.000
C76.3 Pelvis	0.326	0.674	0.000
C80.9 Malignant neoplasm, unspecified	0.305	0.695	0.000
C76.2 Abdomen	0.304	0.695	0.000
C76.1 Thorax	0.287	0.713	0.000
C78.1 Secondary malignant neoplasm of mediastinum	0.279	0.720	0.000
C76.8 Overlapping lesion of other and ill-defined sites	0.277	0.723	0.000
C76.7 Other ill-defined sites	0.277	0.723	0.000
C76.5 Lower limb	0.277	0.723	0.000
C76.4 Upper limb	0.277	0.723	0.000
C77.2 Intra-abdominal lymph nodes	0.271	0.729	0.000
I83 Varicose veins of lower extremities	0.000	0.751	0.249
D12.6 Colon, unspecified	0.000	0.753	0.247
C76.0 Head, face and neck	0.234	0.766	0.000
C77.3 Axillary and upper limb lymph nodes	0.231	0.769	0.000
C80.0 Malignant neoplasm, primary site unknown, so stated	0.213	0.787	0.000
I83.0 Varicose veins of lower extremities with ulcer	0.000	0.801	0.199
Z51.5 Palliative care	0.193	0.807	0.000
Z51 Other medical care	0.184	0.816	0.000
Z51.3 Blood transfusion without reported diagnosis	0.183	0.817	0.000
Z51.8 Other specified medical care	0.183	0.817	0.000
I83.2 Varicose veins of lower extremities with both ulcer and inflammation	0.000	0.826	0.174
Z51.6 Desensitisation to allergens	0.146	0.854	0.000
I83.1 Varicose veins of lower extremities with inflammation	0.000	0.854	0.146
Z51.1 Chemotherapy session for neoplasm	0.141	0.859	0.000
C77.1 Intrathoracic lymph nodes	0.137	0.862	0.000
Z51.9 Medical care, unspecified	0.134	0.866	0.000
C77.0 Lymph nodes of head, face and neck	0.116	0.883	0.000
Z51.4 Preparatory care for treatment, not elsewhere classified	0.116	0.884	0.000
C79 Secondary malignant neoplasm of other sites	0.106	0.894	0.000
D12.8 Rectum	0.000	0.901	0.099
C79.1 Secondary malignant neoplasm of bladder and other and unspecified urinary organs	0.086	0.914	0.000
C79.2 Secondary malignant neoplasm of skin	0.083	0.917	0.000
C79.8 Secondary malignant neoplasm of other specified sites	0.078	0.922	0.000
C79.4 Secondary malignant neoplasm of other and unspecified parts of nervous system	0.077	0.923	0.000
C79.9 Secondary malignant neoplasm, unspecified site	0.074	0.925	0.000
C79.0 Secondary malignant neoplasm of kidney and renal pelvis	0.060	0.940	0.000
C79.7 Secondary malignant neoplasm of adrenal gland	0.059	0.941	0.000
C79.6 Secondary malignant neoplasm of ovary	0.055	0.945	0.000
C79.5 Secondary malignant neoplasm of bone and bone marrow	0.046	0.954	0.000
C79.3 Secondary malignant neoplasm of brain and cerebral meninges	0.041	0.959	0.000
Z51.2 Other chemotherapy	0.039	0.961	0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.000	0.969	0.031
T42.4 Benzodiazepines	0.000	0.969	0.031
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.000	0.971	0.029
H35.3 Degeneration of macula and posterior pole	0.024	0.976	0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.000	0.979	0.021
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.000	0.979	0.021
T42.5 Mixed antiepileptics, not elsewhere classified	0.000	0.979	0.021
T42.3 Barbiturates	0.000	0.979	0.021
T42.2 Succinimides and oxazolidinediones	0.000	0.979	0.021
T42.1 Iminostilbenes	0.000	0.979	0.021
T42.0 Hydantoin derivatives	0.000	0.981	0.019
H35 Other retinal disorders	0.018	0.982	0.000
H35.0 Background retinopathy and retinal vascular changes	0.016	0.984	0.000
H35.5 Hereditary retinal dystrophy	0.016	0.984	0.000
J45.9 Asthma, unspecified	0.016	0.984	0.000
J69.0 Pneumonitis due to food and vomit	0.016	0.984	0.000
H35.2 Other proliferative retinopathy	0.015	0.985	0.000
H35.7 Separation of retinal layers	0.015	0.985	0.000
H35.6 Retinal haemorrhage	0.014	0.986	0.000
H35.1 Retinopathy of prematurity	0.013	0.987	0.000
H35.9 Retinal disorder, unspecified	0.013	0.987	0.000
H35.4 Peripheral retinal degeneration	0.012	0.988	0.000
H35.8 Other specified retinal disorders	0.010	0.990	0.000
N45.9 Orchitis, epididymitis and epididymo-orchitis without abscess	0.009	0.991	0.000
J69 Pneumonitis due to solids and liquids	0.008	0.992	0.000
S92.30 Fracture of metatarsal bone (closed)	0.000	0.992	0.008
Z97.5 Presence of (intra-uterine) contraceptive device	0.007	0.993	0.000
Z51.0 Radiotherapy session	0.007	0.993	0.000
J69.8 Pneumonitis due to other solids and liquids	0.006	0.993	0.000
T36-T50 Poisoning by drugs, medicaments and biological substances	0.000	0.994	0.006
J69.1 Pneumonitis due to oils and essences	0.006	0.994	0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.000	0.994	0.006
S92.3 Fracture of metatarsal bone	0.000	0.994	0.006
M41.96 Scoliosis, unspecified (Lumbar region)	0.006	0.994	0.000
O72.2 Delayed and secondary postpartum haemorrhage	0.006	0.994	0.000
R68.8 Other specified general symptoms and signs	0.006	0.994	0.000
D27 Benign neoplasm of ovary	0.000	0.994	0.006
O72.1 Other immediate postpartum haemorrhage	0.006	0.994	0.000
O72 Postpartum haemorrhage	0.006	0.994	0.000
O72.0 Third-stage haemorrhage	0.005	0.995	0.000
T43.0 Tricyclic and tetracyclic antidepressants	0.000	0.995	0.005
T43.2 Other and unspecified antidepressants	0.000	0.995	0.005
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.000	0.995	0.005
T43.5 Other and unspecified antipsychotics and neuroleptics	0.000	0.995	0.005
R68.0 Hypothermia, not associated with low environmental temperature	0.005	0.995	0.000
T43.3 Phenothiazine antipsychotics and neuroleptics	0.000	0.995	0.005
M41.9 Scoliosis, unspecified	0.005	0.995	0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.000	0.995	0.005
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.000	0.995	0.005
T41 Poisoning by anaesthetics and therapeutic gases	0.000	0.995	0.005
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.000	0.995	0.005
H80.9 Otosclerosis, unspecified	0.005	0.995	0.000
N45 Orchitis and epididymitis	0.005	0.995	0.000
C54.1 Endometrium	0.005	0.995	0.000
R68 Other general symptoms and signs	0.005	0.995	0.000
T43.9 Psychotropic drug, unspecified	0.000	0.995	0.005
T43.8 Other psychotropic drugs, not elsewhere classified	0.000	0.995	0.005
T43.6 Psychostimulants with abuse potential	0.000	0.995	0.005
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.000	0.995	0.005
J45 Asthma	0.005	0.995	0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.000	0.995	0.005
S92.31 Fracture of metatarsal bone (open)	0.000	0.995	0.004
C54 Malignant neoplasm of corpus uteri	0.004	0.995	0.000
S92 Fracture of foot, except ankle	0.000	0.996	0.004
T40.2 Other opioids	0.000	0.996	0.004
C51-C58 Malignant neoplasms of female genital organs	0.004	0.996	0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.000	0.996	0.004
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.000	0.996	0.004
M41.90 Scoliosis, unspecified (Multiple sites in spine)	0.004	0.996	0.000
M41.95 Scoliosis, unspecified (Thoracolumbar region)	0.004	0.996	0.000
T36 Poisoning by systemic antibiotics	0.000	0.996	0.004
C56 Malignant neoplasm of ovary	0.004	0.996	0.000
O72.3 Postpartum coagulation defects	0.004	0.996	0.000
N45.0 Orchitis, epididymitis and epididymo-orchitis with abscess	0.004	0.996	0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.000	0.996	0.004
T43.4 Butyrophenone and thioxanthene neuroleptics	0.000	0.996	0.004
M41.94 Scoliosis, unspecified (Thoracic region)	0.004	0.996	0.000
Y40.0 Penicillins	0.004	0.996	0.000
R68.2 Dry mouth, unspecified	0.004	0.996	0.000
C55 Malignant neoplasm of uterus, part unspecified	0.004	0.996	0.000
S82.40 Fracture of fibula alone (closed)	0.000	0.996	0.004
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.000	0.996	0.004
T40.8 Lysergide [LSD]	0.000	0.996	0.004
T40.7 Cannabis (derivatives)	0.000	0.996	0.004
T40.5 Cocaine	0.000	0.996	0.004
T40.3 Methadone	0.000	0.996	0.004
T40.1 Heroin	0.000	0.996	0.004
T40.0 Opium	0.000	0.996	0.004
C51 Malignant neoplasm of vulva	0.004	0.996	0.000
M31.6 Other giant cell arteritis	0.000	0.996	0.004
S92.4 Fracture of great toe	0.000	0.996	0.004
Z29.2 Other prophylactic chemotherapy	0.004	0.996	0.000
T46 Poisoning by agents primarily affecting the cardiovascular system	0.000	0.996	0.004
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.000	0.996	0.004
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.000	0.996	0.004
T40.4 Other synthetic narcotics	0.000	0.996	0.004
T40.6 Other and unspecified narcotics	0.000	0.996	0.004
H30-H36 Disorders of choroid and retina	0.004	0.996	0.000
M41.98 Scoliosis, unspecified (Sacral and sacrococcygeal region)	0.004	0.996	0.000
M41.97 Scoliosis, unspecified (Lumbosacral region)	0.004	0.996	0.000
M41.93 Scoliosis, unspecified (Cervicothoracic region)	0.004	0.996	0.000
M41.92 Scoliosis, unspecified (Cervical region)	0.004	0.996	0.000
M41.91 Scoliosis, unspecified (Occipito-atlanto-axial region)	0.004	0.996	0.000
S92.2 Fracture of other tarsal bone(s)	0.000	0.996	0.004
S92.7 Multiple fractures of foot	0.000	0.996	0.004
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.000	0.996	0.003
T37.8 Other specified systemic anti-infectives and antiparasitics	0.000	0.996	0.003
T37.5 Antiviral drugs	0.000	0.996	0.003
T37.4 Anthelminthics	0.000	0.996	0.003
T37.3 Other antiprotozoal drugs	0.000	0.996	0.003
T37.2 Antimalarials and drugs acting on other blood protozoa	0.000	0.996	0.003
T37.1 Antimycobacterial drugs	0.000	0.996	0.003
T37.0 Sulphonamides	0.000	0.996	0.003
T41.5 Therapeutic gases	0.000	0.996	0.003
T41.4 Anaesthetic, unspecified	0.000	0.996	0.003
T41.3 Local anaesthetics	0.000	0.996	0.003
T41.2 Other and unspecified general anaesthetics	0.000	0.996	0.003
T41.1 Intravenous anaesthetics	0.000	0.996	0.003
T41.0 Inhaled anaesthetics	0.000	0.996	0.003
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.000	0.996	0.003
T48.6 Antiasthmatics, not elsewhere classified	0.000	0.996	0.003
T48.5 Anti-common-cold drugs	0.000	0.996	0.003
T48.4 Expectorants	0.000	0.996	0.003
T48.3 Antitussives	0.000	0.996	0.003
T48.2 Other and unspecified agents primarily acting on muscles	0.000	0.996	0.003
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.000	0.996	0.003
T48.0 Oxytocic drugs	0.000	0.996	0.003
T49.9 Topical agent, unspecified	0.000	0.996	0.003
T49.8 Other topical agents	0.000	0.996	0.003
T49.7 Dental drugs, topically applied	0.000	0.996	0.003
T49.6 Otorhinolaryngological drugs and preparations	0.000	0.996	0.003
T49.5 Ophthalmological drugs and preparations	0.000	0.996	0.003
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.000	0.996	0.003
T49.3 Emollients, demulcents and protectants	0.000	0.996	0.003
T49.2 Local astringents and local detergents	0.000	0.996	0.003
T49.1 Antipruritics	0.000	0.996	0.003
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.000	0.996	0.003
S92.0 Fracture of calcaneus	0.000	0.996	0.004
C51.9 Vulva, unspecified	0.004	0.996	0.000
R68.3 Clubbing of fingers	0.003	0.996	0.000
R68.1 Nonspecific symptoms peculiar to infancy	0.003	0.996	0.000
J45.8 Mixed asthma	0.003	0.996	0.000
J45.1 Nonallergic asthma	0.003	0.996	0.000
C54.9 Corpus uteri, unspecified	0.003	0.996	0.000
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.000	0.996	0.003
T39.4 Antirheumatics, not elsewhere classified	0.000	0.996	0.003
T39.2 Pyrazolone derivatives	0.000	0.996	0.003
T39.1 4-Aminophenol derivatives	0.000	0.996	0.004
O16 Unspecified maternal hypertension	0.000	0.996	0.004
Z29 Need for other prophylactic measures	0.004	0.996	0.000
C54.8 Overlapping lesion of corpus uteri	0.003	0.996	0.000
C54.3 Fundus uteri	0.003	0.996	0.000
C54.2 Myometrium	0.003	0.996	0.000
C54.0 Isthmus uteri	0.003	0.996	0.000
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.000	0.996	0.003
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.000	0.996	0.003
S92.9 Fracture of foot, unspecified	0.000	0.997	0.003
S92.5 Fracture of other toe	0.000	0.997	0.003
S92.1 Fracture of talus	0.000	0.997	0.003
C57 Malignant neoplasm of other and unspecified female genital organs	0.003	0.997	0.000
C58 Malignant neoplasm of placenta	0.003	0.997	0.000
S92.40 Fracture of great toe (closed)	0.000	0.997	0.003
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.000	0.997	0.003
T47.8 Other agents primarily affecting the gastro-intestinal system	0.000	0.997	0.003
T47.7 Emetics	0.000	0.997	0.003
T47.6 Antidiarrhoeal drugs	0.000	0.997	0.003
T47.5 Digestants	0.000	0.997	0.003
T47.4 Other laxatives	0.000	0.997	0.003
T47.3 Saline and osmotic laxatives	0.000	0.997	0.003
T47.2 Stimulant laxatives	0.000	0.997	0.003
T47.0 Histamine H(2)-receptor antagonists	0.000	0.997	0.003
T38.9 Other and unspecified hormone antagonists	0.000	0.997	0.003
T38.8 Other and unspecified hormones and their synthetic substitutes	0.000	0.997	0.003
T38.7 Androgens and anabolic congeners	0.000	0.997	0.003
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.000	0.997	0.003
T38.5 Other oestrogens and progestogens	0.000	0.997	0.003
T38.4 Oral contraceptives	0.000	0.997	0.003
T38.2 Antithyroid drugs	0.000	0.997	0.003
T38.1 Thyroid hormones and substitutes	0.000	0.997	0.003
T38.0 Glucocorticoids and synthetic analogues	0.000	0.997	0.003
T36.9 Systemic antibiotic, unspecified	0.000	0.997	0.003
T36.8 Other systemic antibiotics	0.000	0.997	0.003
T36.7 Antifungal antibiotics, systemically used	0.000	0.997	0.003
T36.6 Rifamycins	0.000	0.997	0.003
T36.5 Aminoglycosides	0.000	0.997	0.003
T36.4 Tetracyclines	0.000	0.997	0.003
T36.2 Chloramphenicol group	0.000	0.997	0.003
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.000	0.997	0.003
T36.0 Penicillins	0.000	0.997	0.003
C52 Malignant neoplasm of vagina	0.003	0.997	0.000
M41.99 Scoliosis, unspecified (Site unspecified)	0.003	0.997	0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.000	0.997	0.003
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.000	0.997	0.003
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.000	0.997	0.003
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.000	0.997	0.003
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.000	0.997	0.003
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.000	0.997	0.003
T44.1 Other parasympathomimetics [cholinergics]	0.000	0.997	0.003
T44.0 Anticholinesterase agents	0.000	0.997	0.003
C53 Malignant neoplasm of cervix uteri	0.003	0.997	0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.000	0.997	0.003
S92.20 Fracture of other tarsal bone(s) (closed)	0.000	0.997	0.003
T39.0 Salicylates	0.000	0.997	0.003
Y40.8 Other systemic antibiotics	0.003	0.997	0.000
S92.41 Fracture of great toe (open)	0.000	0.997	0.003
Z29.1 Prophylactic immunotherapy	0.003	0.997	0.000
Y40 Systemic antibiotics	0.003	0.997	0.000
S92.70 Multiple fractures of foot (closed)	0.000	0.997	0.003
Z97 Presence of other devices	0.003	0.997	0.000
S92.00 Fracture of calcaneus (closed)	0.000	0.997	0.003
H34 Retinal vascular occlusions	0.003	0.997	0.000
C51.8 Overlapping lesion of vulva	0.003	0.997	0.000
C51.2 Clitoris	0.003	0.997	0.000
C51.1 Labium minus	0.003	0.997	0.000
C51.0 Labium majus	0.003	0.997	0.000
Z29.8 Other specified prophylactic measures	0.003	0.997	0.000
H30 Chorioretinal inflammation	0.003	0.997	0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.000	0.997	0.003
T46.8 Antivaricose drugs, including sclerosing agents	0.000	0.997	0.003
T46.7 Peripheral vasodilators	0.000	0.997	0.003
T46.5 Other antihypertensive drugs, not elsewhere classified	0.000	0.997	0.003
T46.3 Coronary vasodilators, not elsewhere classified	0.000	0.997	0.003
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.000	0.997	0.003
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.000	0.997	0.003
H31 Other disorders of choroid	0.003	0.997	0.000
T45.9 Primarily systemic and haematological agent, unspecified	0.000	0.997	0.003
T45.8 Other primarily systemic and haematological agents	0.000	0.997	0.003
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.000	0.997	0.003
T45.6 Fibrinolysis-affecting drugs	0.000	0.997	0.003
T45.4 Iron and its compounds	0.000	0.997	0.003
T45.3 Enzymes, not elsewhere classified	0.000	0.997	0.003
T45.2 Vitamins, not elsewhere classified	0.000	0.997	0.003
T50.8 Diagnostic agents	0.000	0.997	0.003
T50.7 Analeptics and opioid receptor antagonists	0.000	0.997	0.003
T50.6 Antidotes and chelating agents, not elsewhere classified	0.000	0.997	0.003
T50.5 Appetite depressants	0.000	0.997	0.003
T50.4 Drugs affecting uric acid metabolism	0.000	0.997	0.003
T50.3 Electrolytic, caloric and water-balance agents	0.000	0.997	0.003
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.000	0.997	0.003
T50.1 Loop [high-ceiling] diuretics	0.000	0.997	0.003
T50.0 Mineralocorticoids and their antagonists	0.000	0.997	0.003
H32 Chorioretinal disorders in diseases classified elsewhere	0.003	0.997	0.000
S92.21 Fracture of other tarsal bone(s) (open)	0.000	0.997	0.003
S92.71 Multiple fractures of foot (open)	0.000	0.997	0.003
M41 Scoliosis	0.003	0.997	0.000
S92.01 Fracture of calcaneus (open)	0.000	0.997	0.003
T47.1 Other antacids and anti-gastric-secretion drugs	0.000	0.997	0.003
T46.4 Angiotensin-converting-enzyme inhibitors	0.000	0.997	0.003
T36.3 Macrolides	0.000	0.997	0.002
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.000	0.997	0.003
T45.5 Anticoagulants	0.000	0.997	0.003
Z29.9 Prophylactic measure, unspecified	0.003	0.997	0.000
T46.1 Calcium-channel blockers	0.000	0.997	0.003
H31.3 Choroidal haemorrhage and rupture	0.003	0.997	0.000
H34.1 Central retinal artery occlusion	0.003	0.997	0.000
Z21 Asymptomatic human immunodeficiency virus [HIV] infection status	0.003	0.997	0.000
S92.91 Fracture of foot, unspecified (open)	0.000	0.997	0.003
S92.90 Fracture of foot, unspecified (closed)	0.000	0.997	0.003
T45.0 Antiallergic and antiemetic drugs	0.000	0.997	0.003
Z97.3 Presence of spectacles and contact lenses	0.003	0.997	0.000
M41.5 Other secondary scoliosis	0.003	0.997	0.000
Y40.9 Systemic antibiotic, unspecified	0.003	0.997	0.000
Z20-Z29 Persons with potential health hazards related to communicable diseases	0.003	0.997	0.000
S92.51 Fracture of other toe (open)	0.000	0.997	0.003
I87.2 Venous insufficiency (chronic) (peripheral)	0.000	0.997	0.003
Z97.2 Presence of dental prosthetic device (complete)(partial)	0.003	0.997	0.000
M81.40 Drug-induced osteoporosis (Multiple sites)	0.003	0.997	0.000
S92.11 Fracture of talus (open)	0.000	0.997	0.002
T45.1 Antineoplastic and immunosuppressive drugs	0.000	0.997	0.002
H80 Otosclerosis	0.003	0.997	0.000
C57.9 Female genital organ, unspecified	0.002	0.997	0.000
C57.8 Overlapping lesion of female genital organs	0.002	0.997	0.000
C57.7 Other specified female genital organs	0.002	0.997	0.000
C57.4 Uterine adnexa, unspecified	0.002	0.997	0.000
C57.3 Parametrium	0.002	0.997	0.000
C57.2 Round ligament	0.002	0.997	0.000
C57.1 Broad ligament	0.002	0.997	0.000
C57.0 Fallopian tube	0.002	0.997	0.000
S92.50 Fracture of other toe (closed)	0.000	0.997	0.002
M41.56 Other secondary scoliosis (Lumbar region)	0.003	0.997	0.000
Z22 Carrier of infectious disease	0.003	0.997	0.000
S92.10 Fracture of talus (closed)	0.000	0.997	0.002
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.000	0.997	0.002
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.000	0.997	0.002
C53.9 Cervix uteri, unspecified	0.003	0.997	0.000
Y40.1 Cefalosporins and other -lactam antibiotics	0.003	0.997	0.000
I80-I89 Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified	0.000	0.997	0.003
C44.5 Skin of trunk	0.003	0.997	0.000
C53.8 Overlapping lesion of cervix uteri	0.002	0.997	0.000
C53.1 Exocervix	0.002	0.997	0.000
Y40.5 Aminoglycosides	0.003	0.997	0.000
Z97.1 Presence of artificial limb (complete)(partial)	0.003	0.997	0.000
D22.4 Melanocytic naevi of scalp and neck	0.003	0.997	0.000
Z22.8 Carrier of other infectious diseases	0.003	0.997	0.000
H26.8 Other specified cataract	0.003	0.997	0.000
H31.1 Choroidal degeneration	0.002	0.997	0.000
Y40.7 Antifungal antibiotics, systemically used	0.002	0.997	0.000
Y40.6 Rifamycins	0.002	0.997	0.000
Y40.4 Tetracyclines	0.002	0.997	0.000
Y40.2 Chloramphenicol group	0.002	0.997	0.000
Z22.3 Carrier of other specified bacterial diseases	0.003	0.997	0.000
H30.9 Chorioretinal inflammation, unspecified	0.002	0.997	0.000
Z29.0 Isolation	0.002	0.997	0.000
Z47.8 Other specified orthopaedic follow-up care	0.000	0.997	0.003
H34.8 Other retinal vascular occlusions	0.003	0.997	0.000
Z82.3 Family history of stroke	0.003	0.997	0.000
G82.2 Paraplegia, unspecified	0.000	0.997	0.002
H34.9 Retinal vascular occlusion, unspecified	0.002	0.997	0.000
H34.0 Transient retinal artery occlusion	0.002	0.997	0.000
H30.8 Other chorioretinal inflammations	0.002	0.998	0.000
H30.2 Posterior cyclitis	0.002	0.998	0.000
H30.1 Disseminated chorioretinal inflammation	0.002	0.998	0.000
H30.0 Focal chorioretinal inflammation	0.002	0.998	0.000
H31.9 Disorder of choroid, unspecified	0.002	0.998	0.000
H31.4 Choroidal detachment	0.002	0.998	0.000
H31.2 Hereditary choroidal dystrophy	0.002	0.998	0.000
K90.0 Coeliac disease	0.002	0.998	0.000
Z92.1 Personal history of long-term (current) use of anticoagulants	0.002	0.998	0.000
H36 Retinal disorders in diseases classified elsewhere	0.002	0.998	0.000
C53.0 Endocervix	0.002	0.998	0.000
H32.8 Other chorioretinal disorders in diseases classified elsewhere	0.002	0.998	0.000
H32.0 Chorioretinal inflammation in infectious and parasitic diseases classified elsewhere	0.002	0.998	0.000
F43.2 Adjustment disorders	0.002	0.998	0.000
M41.4 Neuromuscular scoliosis	0.002	0.998	0.000
M41.3 Thoracogenic scoliosis	0.002	0.998	0.000
M41.2 Other idiopathic scoliosis	0.002	0.998	0.000
M41.1 Juvenile idiopathic scoliosis	0.002	0.998	0.000
M41.0 Infantile idiopathic scoliosis	0.002	0.998	0.000
J45.0 Predominantly allergic asthma	0.002	0.998	0.000
Z97.0 Presence of artificial eye	0.002	0.998	0.000
H31.8 Other specified disorders of choroid	0.002	0.998	0.000
I87 Other disorders of veins	0.000	0.998	0.002
M17.9 Gonarthrosis, unspecified	0.002	0.998	0.000
M31.3 Wegener's granulomatosis	0.000	0.998	0.002
D61.9 Aplastic anaemia, unspecified	0.002	0.998	0.000
M41.59 Other secondary scoliosis (Site unspecified)	0.002	0.998	0.000
M41.58 Other secondary scoliosis (Sacral and sacrococcygeal region)	0.002	0.998	0.000
M41.57 Other secondary scoliosis (Lumbosacral region)	0.002	0.998	0.000
M41.55 Other secondary scoliosis (Thoracolumbar region)	0.002	0.998	0.000
M41.54 Other secondary scoliosis (Thoracic region)	0.002	0.998	0.000
M41.53 Other secondary scoliosis (Cervicothoracic region)	0.002	0.998	0.000
M41.52 Other secondary scoliosis (Cervical region)	0.002	0.998	0.000
M41.51 Other secondary scoliosis (Occipito-atlanto-axial region)	0.002	0.998	0.000
M41.50 Other secondary scoliosis (Multiple sites in spine)	0.002	0.998	0.000
M31 Other necrotising vasculopathies	0.000	0.998	0.002
Z28 Immunisation not carried out	0.002	0.998	0.000
Z27 Need for immunisation against combinations of infectious diseases	0.002	0.998	0.000
Z26 Need for immunisation against other single infectious diseases	0.002	0.998	0.000
Z25 Need for immunisation against other single viral diseases	0.002	0.998	0.000
Z24 Need for immunisation against certain single viral diseases	0.002	0.998	0.000
Z23 Need for immunisation against single bacterial diseases	0.002	0.998	0.000
Z20 Contact with and exposure to communicable diseases	0.002	0.998	0.000
D47.3 Essential (haemorrhagic) thrombocythaemia	0.002	0.998	0.000
E21.0 Primary hyperparathyroidism	0.002	0.998	0.000
H80.8 Other otosclerosis	0.002	0.998	0.000
H80.2 Cochlear otosclerosis	0.002	0.998	0.000
H80.1 Otosclerosis involving oval window, obliterative	0.002	0.998	0.000
H80.0 Otosclerosis involving oval window, nonobliterative	0.002	0.998	0.000
Z97.4 Presence of external hearing-aid	0.002	0.998	0.000
I85 Oesophageal varices	0.000	0.998	0.002
M41.8 Other forms of scoliosis	0.002	0.998	0.000
Z22.9 Carrier of infectious disease, unspecified	0.002	0.998	0.000
Z22.6 Carrier of human T-lymphotropic virus type 1 [HTLV-1] infection	0.002	0.998	0.000
Z22.4 Carrier of infections with a predominantly sexual mode of transmission	0.002	0.998	0.000
Z22.2 Carrier of diphtheria	0.002	0.998	0.000
Z22.0 Carrier of typhoid	0.002	0.998	0.000
I80.0 Phlebitis and thrombophlebitis of superficial vessels of lower extremities	0.000	0.998	0.002
H31.0 Chorioretinal scars	0.002	0.998	0.000
H34.2 Other retinal artery occlusions	0.002	0.998	0.000
R94.5 Abnormal results of liver function studies	0.000	0.998	0.002
J60-J70 Lung diseases due to external agents	0.002	0.998	0.000
M77.91 Enthesopathy, unspecified (Shoulder region)	0.002	0.998	0.000
I85.0 Oesophageal varices with bleeding	0.000	0.998	0.002
M24.16 Other articular cartilage disorders (Lower leg)	0.002	0.998	0.000
M47.96 Spondylosis, unspecified (Lumbar region)	0.002	0.998	0.000
G61.8 Other inflammatory polyneuropathies	0.002	0.998	0.000
Y40.3 Macrolides	0.002	0.998	0.000
I88 Nonspecific lymphadenitis	0.000	0.998	0.002
D06.9 Cervix, unspecified	0.002	0.998	0.000
K86.1 Other chronic pancreatitis	0.000	0.998	0.002
T50.9 Other and unspecified drugs, medicaments and biological substances	0.000	0.998	0.002
Y42.8 Other and unspecified hormones and their synthetic substitutes	0.002	0.998	0.000
Y42.5 Other oestrogens and progestogens	0.002	0.998	0.000
H36.8 Other retinal disorders in diseases classified elsewhere	0.002	0.998	0.000
M67.8 Other specified disorders of synovium and tendon	0.002	0.998	0.000
G82 Paraplegia and tetraplegia	0.000	0.998	0.002
D22.2 Melanocytic naevi of ear and external auricular canal	0.002	0.998	0.000
N80.1 Endometriosis of ovary	0.002	0.998	0.000
Z22.1 Carrier of other intestinal infectious diseases	0.002	0.998	0.000
M41.09 Infantile idiopathic scoliosis (Site unspecified)	0.002	0.998	0.000
M41.08 Infantile idiopathic scoliosis (Sacral and sacrococcygeal region)	0.002	0.998	0.000
M41.07 Infantile idiopathic scoliosis (Lumbosacral region)	0.002	0.998	0.000
M41.06 Infantile idiopathic scoliosis (Lumbar region)	0.002	0.998	0.000
M41.05 Infantile idiopathic scoliosis (Thoracolumbar region)	0.002	0.998	0.000
M41.04 Infantile idiopathic scoliosis (Thoracic region)	0.002	0.998	0.000
M41.03 Infantile idiopathic scoliosis (Cervicothoracic region)	0.002	0.998	0.000
M41.02 Infantile idiopathic scoliosis (Cervical region)	0.002	0.998	0.000
M41.01 Infantile idiopathic scoliosis (Occipito-atlanto-axial region)	0.002	0.998	0.000
M41.00 Infantile idiopathic scoliosis (Multiple sites in spine)	0.002	0.998	0.000
M41.19 Juvenile idiopathic scoliosis (Site unspecified)	0.002	0.998	0.000
M41.18 Juvenile idiopathic scoliosis (Sacral and sacrococcygeal region)	0.002	0.998	0.000
M41.17 Juvenile idiopathic scoliosis (Lumbosacral region)	0.002	0.998	0.000
M41.16 Juvenile idiopathic scoliosis (Lumbar region)	0.002	0.998	0.000
M41.15 Juvenile idiopathic scoliosis (Thoracolumbar region)	0.002	0.998	0.000
M41.14 Juvenile idiopathic scoliosis (Thoracic region)	0.002	0.998	0.000
M41.13 Juvenile idiopathic scoliosis (Cervicothoracic region)	0.002	0.998	0.000
M41.12 Juvenile idiopathic scoliosis (Cervical region)	0.002	0.998	0.000
M41.11 Juvenile idiopathic scoliosis (Occipito-atlanto-axial region)	0.002	0.998	0.000
M41.10 Juvenile idiopathic scoliosis (Multiple sites in spine)	0.002	0.998	0.000
M41.29 Other idiopathic scoliosis (Site unspecified)	0.002	0.998	0.000
M41.28 Other idiopathic scoliosis (Sacral and sacrococcygeal region)	0.002	0.998	0.000
M41.27 Other idiopathic scoliosis (Lumbosacral region)	0.002	0.998	0.000
M41.26 Other idiopathic scoliosis (Lumbar region)	0.002	0.998	0.000
M41.25 Other idiopathic scoliosis (Thoracolumbar region)	0.002	0.998	0.000
M41.24 Other idiopathic scoliosis (Thoracic region)	0.002	0.998	0.000
M41.23 Other idiopathic scoliosis (Cervicothoracic region)	0.002	0.998	0.000
M41.22 Other idiopathic scoliosis (Cervical region)	0.002	0.998	0.000
M41.21 Other idiopathic scoliosis (Occipito-atlanto-axial region)	0.002	0.998	0.000
M41.20 Other idiopathic scoliosis (Multiple sites in spine)	0.002	0.998	0.000
M41.39 Thoracogenic scoliosis-Site unspe	0.002	0.998	0.000
M41.38 Thoracogenic scoliosis-Sacral/sacrococ	0.002	0.998	0.000
M41.37 Thoracogenic scoliosis-Lumbosacral	0.002	0.998	0.000
M41.36 Thoracogenic scoliosis-Lumbar	0.002	0.998	0.000
M41.35 Thoracogenic scoliosis (Thoracolumbar region)	0.002	0.998	0.000
M41.34 Thoracogenic scoliosis (Thoracic region)	0.002	0.998	0.000
M41.33 Thoracogenic scoliosis (Cervicothoracic region)	0.002	0.998	0.000
M41.32 Thoracogenic scoliosis-Cervical	0.002	0.998	0.000
M41.31 Thoracogenic scoliosis-Occipit-atl-axl	0.002	0.998	0.000
M41.30 Thoracogenic scoliosis (Multiple sites in spine)	0.002	0.998	0.000
M41.49 Neuromuscular scoliosis (Site unspecified)	0.002	0.998	0.000
M41.48 Neuromuscular scoliosis (Sacral and sacrococcygeal region)	0.002	0.998	0.000
M41.47 Neuromuscular scoliosis (Lumbosacral region)	0.002	0.998	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations